The Best Dividend Stocks I'd Buy Right Now

06:30am, Saturday, 05'th Jul 2025
Savvy investors know not to overlook the power of dividends. And Warren Buffett, arguably the savviest investor of all, appreciates dividends, too.
Shares of Pfizer ( NYSE: PFE ) surged 8.24% over the past month, reducing the stock's year-to-date loss to 5.02%.

2 Stocks to Buy With Less Than $50

07:45am, Friday, 04'th Jul 2025
One formula to generate strong returns on equity markets involves investing small amounts of money in top stocks regularly over long periods. Buying fractional shares is one way to apply this strategy
Since late 2022, no investment trend has been hotter on Wall Street than the evolution of artificial intelligence (AI). Allowing AI-empowered software and systems to make split-second decisions and gr
Investors love dividend stocks, especially those with dependable yields of 7% or higher, because they offer a significant income stream and have substantial total return potential.

Pfizer: Options Activity Speaks Bullish

09:53am, Thursday, 03'rd Jul 2025
The call activity above the current Pfizer Inc. share price, increasing call premiums, and the lack of defensive put buying point to options traders expecting Pfizer to move higher from current price.
PFE trades above its 50-day average for over a month, signaling bullish momentum despite COVID revenue declines and patent risks.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high

Is Pfizer Stock a Yield Trap?

04:21am, Thursday, 03'rd Jul 2025
When it comes to your hard-earned money, you have a lot of choices about where to spend it. If your physician prescribes a new branded drug, though, you and your insurance company have few options.
For more than a century, Wall Street has been a bona fide wealth-creating machine. Though other asset classes, including bonds, commodities, and real estate, have also delivered positive long-term ret
In the latest trading session, Pfizer (PFE) closed at $25.32, marking a +1.12% move from the previous day.
The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED li
PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the company's COVID-19 vaccine
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE